Outcomes of surveillance mammography after treatment of primary breast cancer: A population-based case series

Breast Cancer Research and Treatment

Volumn 114, Issue 1, 2009, Pages 169-178

  Paszat, Lawrence ^a   Sutradhar, Rinku ^a   Grunfeld, Eva ^c   Gainford, Corona ^b   Benk, Veronique ^a,d   Bondy, Susan ^a,b   Coyle, Doug ^e   Holloway, Claire ^b   Sawka, Carol ^d,f   Shumak, Rene ^f   Vallis, Katherine ^d   Van Walraven, Carl ^a,e  

^a INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^f CANCER CARE ONTARIO   (Canada)

Author keywords

Breast cancer survivors; Cancer recurrence in initially conserved breast; Metachronous contralateral breast cancer; Surveillance mammography

Indexed keywords

TAMOXIFEN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVOR; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; PARTIAL MASTECTOMY; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CANADA; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POPULATION SURVEILLANCE; PROPORTIONAL HAZARDS MODELS; REGISTRIES; TREATMENT OUTCOME;

EID: 58849100960     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-9986-4     Document Type: Article

References (23)

1. TJ Smith NE Davidson DV Schapira 1999 ASCO 1998 update of recommended breast cancer surveillance guideline J Clin Oncol 17 3 1080 1082
2. E Grunfeld S Dhesy-Thind M Levine 2005 Clinical practice guidelines for the care and treatment of breast cancer: follow up after treatment for breast cancer CMAJ 172 10 1319 1320
3. E Grunfeld H Noorani L McGahan 2002 Surveillance mammography after treatment of primary breast cancer: a systematic review Breast 11 228 235
4. Paszat L, Grunfeld E, van Walraven C et al A population-based cohort study of surveillance mammography after treatment of primary breast cancer. The Canadian Coordinating Office for Health Technology Assessment, Ottawa, Canada. Report number 15. Web publication at www.cadth.ca/media/pdf/102b-survmamm- cohort-tr.e.pdf
5. CA Doubeni TS Field MU Yood 2006 Patterns and predictors of mammography utilization among breast cancer survivors Cancer 106 2482 2488
6. BM Geller K Kerlikowske PA Carney 2003 Mammography surveillance following breast cancer Breast Cancer Res Treat 81 107 115
7. NL Keating MB Landrum E Guadagnoli 2006 Factors related to underuse of surveillance mammogrpahy among breast cancer survivors J Clin Oncol 24 85 94
8. JE Lafata J Simpkins L Schultz 2005 Routine surveillance care after cancer treatment with curative intent Med Care 43 592 599
9. MM Schapira TL McAuliffe AB Nattinger 2000 Underutilization of mammography in older breast cancer survivors Med Care 38 281 289
10. TL Lash K Clough-Gor RA Silliman 2005 Reduced rates of cancer-related worries and mortality associated with guideline surveillance after breast cancer therapy Breast Cancer Res Treat 89 61 67
11. TL Lash MP Fox RA Silliman 2006 Reduced mortality rate associated with annual mammograms after breast cancer therapy Breast J 12 2 6
12. Lash TL, Fox MP, Buist DSM, Wei F, Field TS, Frost FJ, Geiger AM, Quinn VP, Ulcickas-Yood M, Silliman RA (2007) Mammography surveillance and mortality in older breast cancer survivors. J Clin Oncol 25(21), epub ahead of print. Accessed June 8, 2007
13. Cleveland WS, Grosse E, Shyu WM (1992) Local regression models. In: Chambers JM, Hasties TJ (eds) Statistical models, Chap. 8. Wadsworth Brooks Cole
14. RJ Connor R Boer PC Prorok DL Weed 2000 Investigation of design and bias issues in case-control studies of cancer screening, using microsimulation Am J Epidemiol 151 10 991 998
15. RD Etzioni NS Weiss 1998 Analysis of case-control studies of screening: impact of misspecifying the duration of detectable preclinical pathologic changes Am J Epidemiol 148 3 292 297
16. RS Hosek WD Flandes AJ Sasco 1996 Bias in case-control studies of sceening effectiveness Am J Epidemiol 143 2 193 201
17. AR Localio L Zhou SA Norman 2006 Measuring screening intensity in case-control studies of the efficacy of mammography Am J Epidemiol 164 272 281
18. AJ Sasco NE Day SD Walter 1986 Case-control studies for the evaluation of screening J Chron Dis 39 5 399 405
19. N Weiss 1999 Case-control studies of the efficacy of screening tests designed to prevent the incidence of cancer Am J Epidemiol 149 1 1 4
20. NS Weiss R Etzioni 2002 Estimating the influence of rescreening interval on the benefits associated with cancer screening: approaches and limitations Epidemiology 13 713 717
21. NS Weiss 2003 Adjusting for screening history in epidemiologic studies of cancer: why, when, and how to do it Am J Epidemiol 157 11 957 961
22. J Mandelblatt CB Schechter W Lawrence B Yi J Cullen 2006 The SPECTRUM model of the impact of screening and treatment on US breast cancer trends from 1975 to 2000: principles and practice of the model methods J Natl Cancer Inst Monogr 36 47 55
23. J Lindsey L Ryan 1993 A three-state multiplicative model for rodent tumorigencity experiments Appl Stat 43 293 300